(Q37146126)

18 August 2017

1 reference

title

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases (English)

1 reference

18 August 2017

0 references

0 references

Hans Helmut Niller

1

1 reference

18 August 2017

Hans Wolf

series ordinal

2

1 reference

18 August 2017

Janos Minarovits

series ordinal

3

1 reference

18 August 2017

publication date

1 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

41

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

298-328

1 reference

A sarcoma involving the jaws in African children

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

A children's cancer dependent on climatic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Biology and disease associations of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The immunology of Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Nucleoprotein complexes and DNA 5'-ends at oriP of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The minimal replicator of Epstein-Barr virus oriP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

ORC binding to TRF2 stimulates OriP replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

A second site for Epstein-Barr virus shedding: the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Reactivation of Epstein-Barr virus from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus immortalization and latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein-Barr virus small RNA EBER-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The role of Epstein-Barr virus in neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Post-transplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Comparative studies on adult donor lymphocytes infected by EB virusin vivo orin vitro: Origin of transformed cells arising in co-cultures with foetal lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Molecular biology of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

EBV and Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

EBV-associated neoplasms: alternative pathogenetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Biology of Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Focus on nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Nasopharyngeal carcinoma. X. Presence of Epstein-Barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus-activating principle in the ether extracts of soils collected from under plants which contain active diterpene esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Detection of Epstein-Barr virus in invasive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

No significant association of Epstein-Barr virus infection with invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus: the impact of scientific advances on clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Circulating Epstein-Barr virus-carrying B cells in acute malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Persistent Epstein-Barr viral reactivation in young African children with a history of severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Circulating Epstein-Barr virus in children living in malaria-endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Identification of a polyclonal B-cell activator in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

A molecular link between malaria and Epstein-Barr virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Raised antibody titres to E.B. virus in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Current topics in human SLE genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epidemiologic evidence for multiple sclerosis as an infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Multiple sclerosis in the Faroe Islands: an epitome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus in pediatric multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Multiple sclerosis is linked to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus latent membrane protein 2A and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Quantitation of precipitating antibodies to certain soluble nuclear antigens in sle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The curiously suspicious: a role for Epstein-Barr virus in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Genetics of susceptibility and severity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The type I interferon system in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

TLR7 ligands induce higher IFN-alpha production in females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Association of Epstein-Barr virus with systemic lupus erythematosus - effect modification by race, age, and cytotoxic T lymphocyte-associate antigen 4 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Environment and systemic lupus erythematosus: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Correlation between chlamydial infection and autoimmune response: molecular mimicry between RNA polymerase major sigma subunit from Chlamydia trachomatis and human L7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Antibodies to vesicular stomatitis virus proteins in patients with systemic lupus erythematosus and in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Peptide Mimics of a Major Lupus Epitope of SmB/B′

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary i

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

EBV and systemic lupus erythematosus: a new perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The TNF family members BAFF and APRIL: the growing complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Defective B cell tolerance checkpoints in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

A distinct signaling pathway used by the IgG-containing B cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Infectious mononucleosis patients temporarily recognize a unique, cross‐reactive epitope of Epstein‐Barr virus nuclear antigen‐1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus and rheumatoid arthritis: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

What is after cytokine-blocking therapy, a novel therapeutic target--synovial Epstein-Barr virus for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Risk factors for the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Infection and musculoskeletal conditions: Viral causes of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Rheumatoid arthritis: are pets implicated in its etiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Acute Polyarthritis Associated With Active Epstein-Barr Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein‐Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real‐time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Cross-reactivity between the EBNA-1 p107 peptide, collagen, and keratin: Implications for the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Remission of rheumatoid arthritis after acute disseminated varicella-zoster infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Relationships between chromatin organization and DNA methylation in determining gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

DNA methylation, methyltransferases, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

DNA methylation and chromatin - unraveling the tangled web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Chromatin structure of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lytic cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Host cell phenotype-dependent methylation patterns of Epstein--Barr virus DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

21 January 2018

Locus control regions

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

De novo DNA methylation at nonrandom founder sites 5' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Cell cycle regulation of chromatin at an origin of DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Chromatin profiling of Epstein-Barr virus latency control region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The lytic transition of Epstein-Barr virus is imitated by recombinant B-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Activation of the epstein-barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

Multiple Sclerosis After Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802024772

10.1080/08916930802024772

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference